国家科技部中国科技论文统计源期刊   中国科技核心期刊   WHO西太平洋地区医学索引(WPRIM)收录期刊   湖北优秀期刊
《药物流行病学杂志》官方网站与投审稿系统变更通知<点击查看详情>
康艾注射液上市后医院集中监测
Analysis of Clinical Use of Post marketing Hospital Centralized Monitoring of Kangai Injection
  
DOI:
中文关键词:  康艾注射液  医院集中监测  上市后再评价  合理用药  药品不良反应
英文关键词:Kangai injection  Hospital centralized monitoring  Post marketing reassessment  Rational drug use  Adverse drug reaction
基金项目:
作者单位
陶娌娜 张越 张四喜 宋燕青 吉林大学第一医院药学部 长春 130021 
摘要点击次数: 1366
全文下载次数: 1764
中文摘要:
      摘 要 目的:对康艾注射液上市后临床应用情况进行评价,为规范和指导临床合理用药提供依据。方法:采用医院集中监测的方法,以本院2016年11月~2017年3月入院并使用康艾注射液的住院患者为研究对象,记录患者基本情况、用药情况和药品不良反应发生情况,并评价用药合理性。 结果:共观察病例1 000例,其中超适应证用药占2.5%,用药剂量不足占2.1%,超疗程用药占0.8%,溶媒剂量不足占0.5%。1例患者发生药品不良反应,发生率为0.1%。结论:康艾注射液临床应用欠规范,提示临床用药应严格按照说明书规定适应证、疗程和用法用量,并密切监护患者有无不良反应发生等。
英文摘要:
      ABSTRACT Objective: To assess the clinical use and occurance of adverse reactions of Kangai injection, and to provide reference for rational drug use. Methods:Based on hospital centralized monitoring method, the clinical data of Kangai injection in our hospital from November 2016 to March 2017 was tracked and analyzed.Results:A total of 1 000 inpatients were enrolled in this study. Among them, 2.5% were not in accordance with the medication purpose, 2.1% received unsuitable dose, 0.8% were received a over long course of treatment and 0.5% received unsuitable solvent dose. And 1 cases of adverse drug reaction (ADR) were monitored, with the ADR incidence rate of 0.1%. Conclusion: The clinical use of Kangai injection in our hospital is partly irrational. In order to ensure the safe, effective and economical use, the drug should be strictly used according to the instructions.
查看全文  查看/发表评论  下载PDF阅读器
关闭